CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


PectinWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug2080 Respiratory Mechanics Wiki 1.00
drug106 Acacia Senegal Wiki 1.00
drug2312 Standard Ventilation Strategy Wiki 1.00

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Phase II ,III Randomized Double Blind Parallel Arms Clinical Trial of Potential Role of Gum Arabic ( Acacia Senegal) as Immunomodulatory Agent Among COVID 19 Patients in Sudan

To study the efficacy of Gum Arabic as an immuno modulator and anti-inflammatory agent among COVID 19 seropositive patients..Half of participants will receive Gum Arabic and the other half will receive placebo

NCT04381871 COVID 19 Dietary Supplement: Acacia Senegal Dietary Supplement: Pectin

Primary Outcomes

Description: Changes of the level of Tumor Necrosis Factor (TNF), interleukin IL8,IL6,IL10 from the baseline values

Measure: Mean change from baseline score of Immune Response to end of the trial ( Time Frame: up to 4 weeks )

Time: 4 weeks

Description: The percentage of deaths among COVID 19 patients received Gum Arabic compared to placebo

Measure: Mortality rate

Time: from the date of assignment until the date of first documented progression or date of death from any cause, whichever comes first, assessed up to two months

Secondary Outcomes

Description: Change of viral load from Baseline

Measure: Determine viral load in each patient

Time: 4 weeks

Other Outcomes

Description: Time of discharge from hospital after full recovery

Measure: clinical improvement and hospital discharge

Time: from the date of assignment until the date of hospital discharge for the last assigned case, whichever comes first, assessed up to two months


No related HPO nodes (Using clinical trials)